Skip to main content

ResMed Inc (NYSE: RMD) — Company Overview, News & Financial Data

ResMed Inc logo
RMD ResMed Inc
Company banner image
Company profile

ResMed Inc

ResMed Inc is a global medical technology company that develops, manufactures, and distributes medical equipment and cloud-connected software solutions for respiratory disorders. The company specializes in products for sleep-disordered breathing, including obstructive sleep apnea, as well as chronic obstructive pulmonary disease and other neuromuscular conditions. Its primary hardware offerings include continuous positive airway pressure systems, bi-level devices, ventilators, masks, and accessories. ResMed also provides enterprise software platforms and mobile health applications that assist healthcare providers and patients with out-of-hospital care management, remote monitoring, and diagnostic titration across global healthcare markets.

Snapshot

Public USOwnership
1989Year founded
~11,000Employees
San Diego, United StatesHead office
Loading Map...
Global footprint

Operations

Products and/or services of ResMed Inc

  • Sleep Apnea Devices: Flow generators, continuous positive airway pressure systems, and auto-titrating therapy machines used globally by patients in home and clinical settings to treat obstructive sleep apnea and related sleep-disordered breathing conditions.
  • Masks and Replacement Accessories: Nasal, full-face, and nasal pillow interfaces, together with headgear, cushions, and air tubing designed for continuous positive airway pressure therapy and regularly replaced through home medical equipment supply channels.
  • Respiratory Care and Mechanical Ventilators: Non-invasive and invasive ventilation equipment, high-flow oxygen therapy systems, and portable life support devices designed for patients managing severe chronic obstructive pulmonary disease, neuromuscular conditions, and respiratory failure.
  • Digital Health and Remote Patient Monitoring Software: Cloud-connected digital health platforms, remote therapy monitoring tools, and mobile patient applications that aggregate daily compliance data, streamline clinician workflows, and support long-term sleep apnea treatment adherence.
  • Out-of-Hospital Healthcare Management Software: Enterprise software-as-a-service platforms, electronic health record tools, and business management solutions serving home medical equipment providers, home health agencies, hospice facilities, and private senior living care settings.
  • Sleep Diagnostics and Titration Equipment: Home sleep testing devices, laboratory titration hardware, and clinical evaluation software utilized by sleep diagnostic centers and physicians to analyze sleep patterns and establish appropriate respiratory therapy parameters.

ResMed Inc executive team

  • Michael J. FarrellCEO & Chairman
  • Peter C. FarrellFounder, Chair Emeritus & Non-Executive Director
  • Aaron BloomerChief Financial Officer
  • Michael J. RiderChief Legal Officer & Secretary
  • Brett A. SandercockAdvisor
  • Justin LeongChief Product Officer
  • Alastair RobertsonChief Information Officer
  • Sallilyn SchwartzChief Communications & Investor Relations Officer
  • Jim EllisChief Compliance Officer
  • Yvonne-Katrin PucknatChief Marketing Officer

Recent announcements

What ResMed Inc (RMD) has told the market, newest first.

  1. 4 | RESMED INC
  2. 4 | RESMED INC
  3. 4 | RESMED INC
  4. 4 | RESMED INC
  5. 4 | RESMED INC
  6. 4 | RESMED INC
  7. 4 | RESMED INC
  8. 4 | RESMED INC

Dividend history

Dividends per share paid by ResMed Inc, by financial year.

ResMed Inc dividends per share by financial year
Financial yearInterimFinalSpecialTotal
FY2027(to date)———$1.3200
FY2026———$2.4000
FY2025———$2.1200
FY2024———$1.9200
FY2023———$1.7600

Key financials

Reported results for ResMed Inc, in USD.

Market cap
33.3B
Revenue (TTM)
5.7B
P/E ratio
21.6
EPS (diluted, TTM)
11.0
Dividend yield
1.0%
Profit margin
27.8%
ResMed Inc annual revenue and income
Fiscal year endRevenueOperating incomeNet income
5.7B1.9B1.5B
5.1B1.7B1.4B
4.7B1.3B1B
4.2B1.1B897.6M